InvestorsHub Logo
icon url

MXAMDUD

09/01/16 3:23 PM

#158115 RE: MinnieM #158114

you guys are all confusing a potentially great product with a well-run company & stock.

they can be mutually exclusive and by the 1.30 price/share, looks like the market believes it
icon url

tombrady12nh

09/01/16 3:52 PM

#158119 RE: MinnieM #158114

So are we worth $4.82 now or at the end of 2023?
icon url

Pepperchino

09/01/16 7:59 PM

#158132 RE: MinnieM #158114

This is an amazing analysis...
icon url

Amatuer17

09/01/16 8:50 PM

#158133 RE: MinnieM #158114

Thanks for the contents of report.

Very interesting analysis and key points to note -

1. B-ABSSI which was the star product and with new class and new MOA was supposed to get special approval from fda and was supposed to come to market in 24 months -

Peak sales only 300 million and will come to market in 2020 - 6 years after successful P2. Sad

2. K is not coming to market till 2023 - not even sure it will remain relevant by that time or CTIX survive

3 P - as against some very high peak sales numbers thrown - not very huge

Everything is so far off and no stream of revenue in near future - Aspire is the funding source unless they are lucky to find a partner